Apr 14, 2022
Dave Rosa is the President and CEO of NeuroOne and an entrepreneur with extensive experience in the medical device industry. NeuroOne is developing and commercializing thin-film high-definition electrode technology that can dramatically improve neurosurgery where typically, multiple surgeries are needed for diagnostic...
Apr 14, 2022
Dave Rosa is the President and CEO of NeuroOne and an entrepreneur with extensive experience in the medical device industry. NeuroOne is developing and commercializing thin-film high-definition electrode technology that can dramatically improve neurosurgery where typically, multiple surgeries are needed for diagnostic...
Apr 13, 2022
Tim Dyer is the Co-Founder and CEO of Addex Therapeutics, which is focusing on the pharmacology known as allosteric modulation. This emerging class of small molecule drugs known as allosteric modulators is being explored for treating central nervous system and neurologic disorders, particularly movement disorders like...
Apr 13, 2022
Tim Dyer is the Co-Founder and CEO of Addex Therapeutics, which is focusing on the pharmacology known as allosteric modulation. This emerging class of small molecule drugs known as allosteric modulators is being explored for treating central nervous system and neurologic disorders, particularly movement disorders like...
Mar 15, 2022
Micha Breakstone is the CEO and Co-Founder of NeuraLight and points out the lack of objective and sensitive evaluation measures available to diagnose neurological diseases like multiple sclerosis, Alzheimer's, and Parkinson's. Currently, evaluations using short questionnaires, visual observations, and self-reported...